Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
Condition(s):Breast Cancer; Osteoporosis, OsteopeniaLast Updated:January 17, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Breast Cancer; Osteoporosis, OsteopeniaLast Updated:January 17, 2019Unknown status
Condition(s):Alcohol Use Disorder; Alcoholic Liver Disease; MicrobiomeLast Updated:September 22, 2023Recruiting
Condition(s):Obesity, ChildhoodLast Updated:August 21, 2020Completed
Condition(s):ObesityLast Updated:July 28, 2017Completed
Condition(s):Ulcerative ColitisLast Updated:March 22, 2022Completed
Condition(s):Colorectal CancerLast Updated:March 15, 2023Withdrawn
Condition(s):Metabolic SyndromeLast Updated:December 11, 2013Completed
Condition(s):HealthyLast Updated:March 23, 2018Completed
Condition(s):Menopausal OsteoporosisLast Updated:March 4, 2020Terminated
Condition(s):Stress, PsychologicalLast Updated:October 19, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.